The EMUC24 scientific programme will comprise in-depth lectures, practical hands-on training courses, and multidisciplinary case discussions. Being the only interdisciplinary event of its kind in Europe, EMUC24 will identify the best therapies, examine current practices, address controversies, and review emerging technologies.
This year EMUC will also collaborate with the Kidney Cancer Association (KCA), bringing in some vital knowledge about the latest on kidney cancer.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze